nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—SLC22A5—Dactinomycin—ocular cancer	0.78	1	CbGbCtD
L-Arginine—AZIN2—Amino acid and derivative metabolism—PSPH—ocular cancer	0.0168	0.0761	CbGpPWpGaD
L-Arginine—ASL—Amino acid and derivative metabolism—PSPH—ocular cancer	0.0153	0.0696	CbGpPWpGaD
L-Arginine—ARG2—Amino acid and derivative metabolism—PSPH—ocular cancer	0.0127	0.0577	CbGpPWpGaD
L-Arginine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—ocular cancer	0.0111	0.0504	CbGpPWpGaD
L-Arginine—ASS1—Amino acid and derivative metabolism—PSPH—ocular cancer	0.00881	0.04	CbGpPWpGaD
L-Arginine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	0.00826	0.0375	CbGpPWpGaD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—ID2—ocular cancer	0.00716	0.0325	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—E2F5—ocular cancer	0.0042	0.0191	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—GNA11—ocular cancer	0.00408	0.0185	CbGpPWpGaD
L-Arginine—NOS3—PAR1-mediated thrombin signaling events—GNA11—ocular cancer	0.00393	0.0178	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—GNAQ—ocular cancer	0.00379	0.0172	CbGpPWpGaD
L-Arginine—NOS3—PAR1-mediated thrombin signaling events—GNAQ—ocular cancer	0.00365	0.0166	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—CRTC1—ocular cancer	0.0033	0.015	CbGpPWpGaD
L-Arginine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.00322	0.0146	CbGpPWpGaD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—GNA11—ocular cancer	0.00318	0.0144	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PSPH—ocular cancer	0.00308	0.014	CbGpPWpGaD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—GNAQ—ocular cancer	0.00295	0.0134	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—ID2—ocular cancer	0.00294	0.0133	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PSPH—ocular cancer	0.00282	0.0128	CbGpPWpGaD
L-Arginine—NOS3—eNOS activation—AKT1—ocular cancer	0.00277	0.0126	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—MYBL2—ocular cancer	0.00248	0.0113	CbGpPWpGaD
L-Arginine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.00247	0.0112	CbGpPWpGaD
L-Arginine—NOS3—ACE Inhibitor Pathway—TGFB1—ocular cancer	0.0024	0.0109	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PSPH—ocular cancer	0.00233	0.0106	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—CDK4—ocular cancer	0.00221	0.01	CbGpPWpGaD
L-Arginine—NOS3—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—AKT1—ocular cancer	0.0022	0.01	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—GNA11—ocular cancer	0.00214	0.00971	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—GNAQ—ocular cancer	0.00199	0.00902	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—RB1—ocular cancer	0.00192	0.00872	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PSPH—ocular cancer	0.00162	0.00735	CbGpPWpGaD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—ocular cancer	0.00161	0.0073	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—E2F1—ocular cancer	0.00155	0.00706	CbGpPWpGaD
L-Arginine—NOS3—Metabolism of nitric oxide—AKT1—ocular cancer	0.00152	0.00692	CbGpPWpGaD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—ocular cancer	0.00148	0.00672	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—GNA11—ocular cancer	0.00147	0.00669	CbGpPWpGaD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—ocular cancer	0.00143	0.00647	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—CCND1—ocular cancer	0.00142	0.00647	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—GNAQ—ocular cancer	0.00137	0.00622	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—CDK2—ocular cancer	0.00134	0.00609	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—EP300—ocular cancer	0.00131	0.00596	CbGpPWpGaD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—GNAQ—ocular cancer	0.00131	0.00594	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—CDK4—ocular cancer	0.00127	0.00576	CbGpPWpGaD
L-Arginine—NOS3—Angiogenesis—AKT1—ocular cancer	0.00126	0.00574	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—HDAC1—ocular cancer	0.00123	0.00561	CbGpPWpGaD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—ocular cancer	0.00122	0.00555	CbGpPWpGaD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.0012	0.00545	CbGpPWpGaD
L-Arginine—NOS3—VEGFR2 mediated vascular permeability—AKT1—ocular cancer	0.00112	0.00508	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—RB1—ocular cancer	0.0011	0.00501	CbGpPWpGaD
L-Arginine—NOS3—VEGFR1 specific signals—AKT1—ocular cancer	0.00109	0.00493	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—MYC—ocular cancer	0.00103	0.00469	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—GNA11—ocular cancer	0.000969	0.0044	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—E2F1—ocular cancer	0.000937	0.00426	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—HRAS—ocular cancer	0.000933	0.00424	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—CCND1—ocular cancer	0.000913	0.00415	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—GNAQ—ocular cancer	0.000901	0.00409	CbGpPWpGaD
L-Arginine—ASL—Metabolism—GNA11—ocular cancer	0.000886	0.00402	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—CDKN1B—ocular cancer	0.000858	0.0039	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—ocular cancer	0.000848	0.00385	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—CDK4—ocular cancer	0.000828	0.00376	CbGpPWpGaD
L-Arginine—ASL—Metabolism—GNAQ—ocular cancer	0.000824	0.00374	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—AKT1—ocular cancer	0.000823	0.00374	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—CCND1—ocular cancer	0.000818	0.00372	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—HRAS—ocular cancer	0.000811	0.00368	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—GNA11—ocular cancer	0.000734	0.00333	CbGpPWpGaD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000725	0.00329	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—AKT1—ocular cancer	0.000725	0.00329	CbGpPWpGaD
L-Arginine—NOS2—Disease—SAG—ocular cancer	0.000717	0.00326	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—AKT1—ocular cancer	0.000716	0.00325	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—HRAS—ocular cancer	0.000707	0.00321	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PSPH—ocular cancer	0.000704	0.0032	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—GNA11—ocular cancer	0.000704	0.0032	CbGpPWpGaD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—AKT1—ocular cancer	0.000703	0.00319	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—GNAQ—ocular cancer	0.000682	0.0031	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—MYC—ocular cancer	0.000656	0.00298	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—TGFB1—ocular cancer	0.000655	0.00297	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—GNAQ—ocular cancer	0.000654	0.00297	CbGpPWpGaD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—AKT1—ocular cancer	0.000642	0.00291	CbGpPWpGaD
L-Arginine—NOS2—Disease—E2F5—ocular cancer	0.000635	0.00288	CbGpPWpGaD
L-Arginine—NOS2—Disease—E2F4—ocular cancer	0.000622	0.00282	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—TGFB1—ocular cancer	0.00062	0.00282	CbGpPWpGaD
L-Arginine—NOS2—Disease—RPL39—ocular cancer	0.00061	0.00277	CbGpPWpGaD
L-Arginine—NOS2—Disease—RBL1—ocular cancer	0.00061	0.00277	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—HDAC1—ocular cancer	0.00059	0.00268	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—HRAS—ocular cancer	0.000575	0.00261	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—AKT1—ocular cancer	0.000563	0.00256	CbGpPWpGaD
L-Arginine—NOS3—Disease—SAG—ocular cancer	0.000557	0.00253	CbGpPWpGaD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—ocular cancer	0.000549	0.0025	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—GNA11—ocular cancer	0.000546	0.00248	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—TP53—ocular cancer	0.000539	0.00245	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—GNA11—ocular cancer	0.000509	0.00231	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—AKT1—ocular cancer	0.000508	0.00231	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—GNAQ—ocular cancer	0.000508	0.00231	CbGpPWpGaD
L-Arginine—NOS3—Disease—E2F5—ocular cancer	0.000493	0.00224	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—EP300—ocular cancer	0.000492	0.00223	CbGpPWpGaD
L-Arginine—NOS2—Disease—TFDP1—ocular cancer	0.000491	0.00223	CbGpPWpGaD
L-Arginine—NOS3—Disease—E2F4—ocular cancer	0.000483	0.00219	CbGpPWpGaD
L-Arginine—NOS3—Disease—RBL1—ocular cancer	0.000473	0.00215	CbGpPWpGaD
L-Arginine—NOS3—Disease—RPL39—ocular cancer	0.000473	0.00215	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—GNAQ—ocular cancer	0.000473	0.00215	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—HDAC1—ocular cancer	0.000458	0.00208	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—HRAS—ocular cancer	0.000433	0.00197	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—AKT1—ocular cancer	0.000431	0.00196	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—CDK2—ocular cancer	0.000418	0.0019	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—HRAS—ocular cancer	0.000409	0.00186	CbGpPWpGaD
L-Arginine—NOS2—Disease—MAML2—ocular cancer	0.00039	0.00177	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SAG—ocular cancer	0.00039	0.00177	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—AKT1—ocular cancer	0.000382	0.00174	CbGpPWpGaD
L-Arginine—NOS3—Disease—TFDP1—ocular cancer	0.000382	0.00173	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—AKT1—ocular cancer	0.000361	0.00164	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—TP53—ocular cancer	0.000352	0.0016	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—E2F5—ocular cancer	0.000345	0.00157	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—E2F4—ocular cancer	0.000338	0.00154	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RBL1—ocular cancer	0.000331	0.00151	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—CDK2—ocular cancer	0.000325	0.00148	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—EP300—ocular cancer	0.000324	0.00147	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—HRAS—ocular cancer	0.000311	0.00141	CbGpPWpGaD
L-Arginine—NOS3—Disease—MAML2—ocular cancer	0.000303	0.00138	CbGpPWpGaD
L-Arginine—ASL—Metabolism—EP300—ocular cancer	0.000296	0.00134	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—E2F3—ocular cancer	0.000287	0.00131	CbGpPWpGaD
L-Arginine—NOS2—Disease—HDAC1—ocular cancer	0.000285	0.0013	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—AKT1—ocular cancer	0.000274	0.00125	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TFDP1—ocular cancer	0.000267	0.00121	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDKN2B—ocular cancer	0.000256	0.00116	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—EP300—ocular cancer	0.000245	0.00111	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—EP300—ocular cancer	0.000235	0.00107	CbGpPWpGaD
L-Arginine—NOS3—Disease—HDAC1—ocular cancer	0.000222	0.00101	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GNA11—ocular cancer	0.000221	0.00101	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MAML2—ocular cancer	0.000212	0.000964	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GNAQ—ocular cancer	0.000206	0.000935	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TGFB1—ocular cancer	0.000204	0.000928	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDKN2B—ocular cancer	0.000199	0.000903	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—AKT1—ocular cancer	0.000196	0.000888	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GNA11—ocular cancer	0.000185	0.000841	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—EP300—ocular cancer	0.000183	0.000829	CbGpPWpGaD
L-Arginine—ASL—Metabolism—AKT1—ocular cancer	0.000179	0.000813	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GNAQ—ocular cancer	0.000172	0.000782	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—EP300—ocular cancer	0.00017	0.000772	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TP53—ocular cancer	0.000168	0.000764	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—HRAS—ocular cancer	0.000161	0.000731	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TGFB1—ocular cancer	0.000159	0.000721	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HDAC1—ocular cancer	0.000155	0.000705	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—AKT1—ocular cancer	0.000148	0.000673	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—AKT1—ocular cancer	0.000142	0.000645	CbGpPWpGaD
L-Arginine—NOS2—Disease—MDM2—ocular cancer	0.000142	0.000645	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDKN2B—ocular cancer	0.000139	0.000632	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TP53—ocular cancer	0.000131	0.000593	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDKN1B—ocular cancer	0.00013	0.000589	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—E2F1—ocular cancer	0.000128	0.00058	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—HRAS—ocular cancer	0.000125	0.000567	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDKN1A—ocular cancer	0.00012	0.000543	CbGpPWpGaD
L-Arginine—NOS2—Disease—EP300—ocular cancer	0.000114	0.000517	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—AKT1—ocular cancer	0.00011	0.000501	CbGpPWpGaD
L-Arginine—NOS3—Disease—MDM2—ocular cancer	0.00011	0.000501	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—AKT1—ocular cancer	0.000103	0.000467	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDKN1B—ocular cancer	0.000101	0.000457	CbGpPWpGaD
L-Arginine—NOS2—Disease—MYC—ocular cancer	9.92e-05	0.00045	CbGpPWpGaD
L-Arginine—NOS2—Disease—TGFB1—ocular cancer	9.89e-05	0.000449	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDKN1A—ocular cancer	9.29e-05	0.000422	CbGpPWpGaD
L-Arginine—NOS3—Disease—EP300—ocular cancer	8.84e-05	0.000401	CbGpPWpGaD
L-Arginine—NOS2—Disease—HRAS—ocular cancer	7.79e-05	0.000354	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MDM2—ocular cancer	7.72e-05	0.000351	CbGpPWpGaD
L-Arginine—NOS3—Disease—MYC—ocular cancer	7.7e-05	0.00035	CbGpPWpGaD
L-Arginine—NOS3—Disease—TGFB1—ocular cancer	7.68e-05	0.000349	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—EP300—ocular cancer	7.4e-05	0.000336	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDKN1B—ocular cancer	7.05e-05	0.00032	CbGpPWpGaD
L-Arginine—NOS2—Disease—AKT1—ocular cancer	6.88e-05	0.000312	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCND1—ocular cancer	6.72e-05	0.000305	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDKN1A—ocular cancer	6.5e-05	0.000295	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EP300—ocular cancer	6.19e-05	0.000281	CbGpPWpGaD
L-Arginine—NOS3—Disease—HRAS—ocular cancer	6.05e-05	0.000275	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MYC—ocular cancer	5.39e-05	0.000245	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TGFB1—ocular cancer	5.38e-05	0.000244	CbGpPWpGaD
L-Arginine—NOS3—Disease—AKT1—ocular cancer	5.34e-05	0.000243	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AKT1—ocular cancer	4.47e-05	0.000203	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TP53—ocular cancer	4.43e-05	0.000201	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HRAS—ocular cancer	4.23e-05	0.000192	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKT1—ocular cancer	3.74e-05	0.00017	CbGpPWpGaD
